ElBayoumi, T. A., & Torchilin, V. P. (2009). Tumor-Targeted Nanomedicines: Enhanced Anti-Tumor Efficacy In vivo of Doxorubicin-Loaded Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody.
Čikaški stil citiranjaElBayoumi, Tamer A., i Vladimir P. Torchilin. Tumor-Targeted Nanomedicines: Enhanced Anti-Tumor Efficacy In Vivo of Doxorubicin-Loaded Long-Circulating Liposomes Modified With Cancer-Specific Monoclonal Antibody. 2009.
MLA način citiranjaElBayoumi, Tamer A., i Vladimir P. Torchilin. Tumor-Targeted Nanomedicines: Enhanced Anti-Tumor Efficacy In Vivo of Doxorubicin-Loaded Long-Circulating Liposomes Modified With Cancer-Specific Monoclonal Antibody. 2009.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.